Endovantage Overview

  • Founded
  • 2013
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 9
Employees
  • Latest Deal Type
  • M&A

Endovantage General Information

Description

Developer of a cloud-based computational platform designed to automate comprehensive cerebral aneurysm management. The company's platform uses a patient's medical scan to create a personalized 3D model of the vasculature and provides accurate, clinically relevant information for aneurysm treatment, enabling doctors to take decision accordingly and treat patients.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Parent Company
Primary Office
  • 8444 North 90th Street
  • Suite 125
  • Scottsdale, AZ 85258
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Endovantage Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 09-Jun-2020 00.000 Completed Generating Revenue
6. Angel (individual) 01-Aug-2015 000 00.000 0000 Completed Startup
5. Grant 01-Mar-2015 00000 0000 Completed Startup
4. Accelerator/Incubator 01-May-2014 0000 0000 Completed Startup
3. Accelerator/Incubator 19-Feb-2014 000 Completed Startup
2. Accelerator/Incubator 05-Sep-2013 $3K $3K Completed Startup
1. Grant 29-May-2013 $3.47M Completed Startup
To view Endovantage’s complete valuation and funding history, request access »

Endovantage Executive Team (4)

Name Title Board Seat Contact Info
Brian Chong MD Co-Founder, Board Member & Chief Medical Officer
David Frakes Ph.D Co-Founder, Board Member & Chief Science Officer
Haithem Babiker Ph.D Co-Founder, Board Member & Chief Technology Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Endovantage Board Members (3)

Name Representing Role Since
Brian Chong MD Endovantage Co-Founder, Board Member & Chief Medical Officer 000 0000
David Frakes Ph.D Endovantage Co-Founder, Board Member & Chief Science Officer 000 0000
Haithem Babiker Ph.D Endovantage Co-Founder, Board Member & Chief Technology Officer 000 0000
To view Endovantage’s complete board members history, request access »

Endovantage Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endovantage Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ASU-Mayo Seed Grant Other 000 0000 000000 0
American Heart Association Corporation 000 0000 000000 0
Arizona Innovation Challenge Not-For-Profit Venture Capital 000 0000 000000 0
Brain Aneursym Foundation Other 000 0000 000000 0
Desert Angels Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »